Nxera Pharma UK Limited
14 clinical trials · Sponsor
◉ Watch Nxera Pharma UK Limited
| Record | Firm | Date |
|---|---|---|
| Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution (NCT04935320) | Nxera Pharma UK Limited | 2021-07-29 |
| Study to Investigate the Receptor Occupancy of HTL0014242 Using [18F] FPEB in Healthy Male Subjects (NCT04462263) | Nxera Pharma UK Limited | 2020-06-29 |
| A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (NCT03592862) | Nxera Pharma UK Limited | 2019-07-01 |
| A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310 (NCT03847207) | Nxera Pharma UK Limited | 2019-01-23 |
| Phase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242 (NCT03785054) | Nxera Pharma UK Limited | 2018-11-14 |
| Measurement of HTL0016878 in Cerebrospinal Fluid (NCT04849286) | Nxera Pharma UK Limited | 2018-09-26 |
| Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care (NCT03456349) | Nxera Pharma UK Limited | 2017-11-10 |
Track Nxera Pharma UK Limited automatically
Every clearance here is in the API, with alerts when new ones post.